InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.
IVRO stock price ended at $0.15 on 水曜日, after rising 15.38%
On the latest trading day Jan 21, 2026, the stock price of IVRO rose by 15.38%, climbing from $0.14 to $0.15. Throughout the session, the stock experienced a volatility of 7.14%, with prices fluctuating between a daily low of $0.14 and a high of $0.15. Alongside this price increase, trading volume also rose by 161.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 134.4K shares were traded, amounting to a market value of approximately $3.4M.